PM360

AUGUST 9, 2022

The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. The Andaman7 Platform Solution. Vincent Keunen.

Prescription 105

Prescription Medical Patients Side effects 105

PM360

NOVEMBER 14, 2023

This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap OOP costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. The price is available to cash-paying patients with a valid prescription. Currently, an estimated 37.3 of the U.S.

Retail 52

Retail Sales Pharmaceutical manufacturing Insurance 52

Penrod

JULY 9, 2024

Google’s Policy Restrictions on Healthcare Advertising Google’s internal rules heavily restrict healthcare players like pharmaceutical manufacturers. For instance, pharmaceutical manufacturers can only promote prescription medicine ads in Canada, the US, and New Zealand – not anywhere else.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Prescription Manufacturing Medical 52

Clarify Health

OCTOBER 26, 2021

of patients are enrolled in clinical trials for first line cancer therapies and enrollment favors young, healthy, white patients with metastatic disease, private insurance, and access to be treated at academic medical centers. [1] However, another study found that 0.1% 2] Figure 1.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52

PM360

DECEMBER 20, 2023

These factors collectively necessitate that foreign pharmaceutical companies develop more comprehensive market access strategies for the Chinese market. National Basic Medical Insurance Over a period of 20 years, China has established its universal healthcare system and achieved a coverage of over 95% of the population (approximately 1.33

Marketing 105

Marketing Insurance Medical Manufacturing 105

Clarivate

AUGUST 20, 2024

Although the reported negotiated prices may ignore the real-world role of contracting by manufacturers and private payers over formulary placement, the reported prices nonetheless are likely to have downstream impacts on how private payers reimburse these therapies and their competitors. These ten drugs cost Medicare Part D nearly $46.8

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52